Anal Cancer Research
Treating High-grade Lesions to Prevent Anal Cancer in HIV-infected PeoplePosted: March 11, 2015
This study, called the ANCHOR trial, will investigate whether screening and prevention methods similar to those used to prevent cervical cancer can help prevent anal cancer in HIV-infected men and women.
Electrocautery Superior to Topical Treatments for Precancerous Anal LesionsPosted: April 4, 2013
Results from a randomized clinical trial conducted in Amsterdam suggest that electrocautery is better than topical imiquimod or fluorouracil at treating potentially precancerous anal lesions in HIV-positive men who have sex with men.
HIV infection connected to rising anal cancer rates in men in the U.S.Posted: October 5, 2012
Human immunodeficiency virus (HIV) infection contributes substantially to the epidemic of anal cancer in men, but not women in the United States, according to new research from NCI. Chart shows overall incidence rates of anal cancers in general population with dashed line showing those with HIV infection.
Vaccine Reduces HPV Infections in Young MenPosted: March 29, 2011
An international randomized clinical trial has shown that the vaccine Gardasil can reduce the incidence of anogenital human papillomavirus (HPV) infections in young men 16 to 26 years of age at the time of vaccination.